INI-CET EXAM -2026
Medical & Surgical Nursing
Easy

A patient develops acute-onset severe unilateral hearing loss with no identifiable cause. Audiometry confirms sensorineural hearing loss. Which of the following pharmacological regimens is considered the first-line treatment for this condition?

Appeared in: INI-CET EXAM -2026

Explanation

  • The clinical presentation describes Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL), which is considered an otologic emergency.
  • Oral systemic corticosteroids, like prednisolone, are the established first-line therapy for ISSNHL.
  • The primary mechanism of action is reducing inflammation and edema within the cochlea and auditory nerve, which is the presumed cause in many idiopathic cases.
  • Early initiation of steroid therapy is critical and is associated with a higher likelihood of partial or complete hearing recovery.

Why Other Options Were Wrong

  • Option A: Intratympanic steroid injections are not the first-line treatment for most patients.
  • Option B: Topical steroid ear drops cannot penetrate the tympanic membrane to reach the inner ear, where the sensorineural hearing loss originates.
  • Option C: Gentamicin is an ototoxic antibiotic that can cause or worsen sensorineural hearing loss. Its use is contraindicated for treating this condition.

Related Visual

Anatomy of the human ear. This visual should clearly label the external, middle, and inner ear including the cochlea and auditory nerve. A caption can explain that in sensorin...
Clinical Relevance
  • Nursing practice connection: Use the key finding related to First-line pharmacological treatment for Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) to guide bedside assessment, documentation, and the next nursing action.
  • Nurses must recognize sudden hearing loss as a medical emergency requiring prompt referral to an otolaryngologist for diagnosis and initiation of time-sensitive treatment.
  • Patient education is a key nursing role, focusing on the importance of adherence to the steroid tapering schedule and monitoring for potential side effects like hyperglycemia, hypertension, mood changes, and insomnia.
  • What if? If the patient had a history of poorly controlled diabetes or a peptic ulcer? In this case, systemic steroids would be relatively contraindicated, and the physician might choose intratympanic steroid injections as the first-line therapy to minimize systemic risks.
How to Approach the Question
  • First, analyze the patient's symptoms: acute onset, unilateral, severe hearing loss confirmed as sensorineural, and idiopathic (no identifiable cause).
  • Recognize this specific constellation of symptoms as the definition of Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL).
  • Recall that ISSNHL is treated as an otologic emergency, and the goal is to reduce inflammation in the inner ear.
  • Evaluate the treatment options based on their ability to deliver an anti-inflammatory agent to the cochlea and auditory nerve.
  • Eliminate options that are ineffective (topical drops) or harmful (ototoxic antibiotics).
  • Differentiate between first-line (systemic steroids) and second-line (intratympanic steroids) therapies to select the correct answer.
Concept Tested & Keywords
  • Concept Tested: First-line pharmacological treatment for Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL).
  • Stem keywords: acute-onset, severe unilateral hearing loss, no identifiable cause, audiometry, sensorineural hearing loss
  • Lead-in keywords: first-line treatment
  • Negative lead-in flag: false

Question ID

Q2vi4n7UPpZkRBEmKjsHSA

Reference Book

E6 Nelson Textbook of Pediatrics(2024) — Volume 2 p. 1802-1804

Practise the full INI-CET EXAM -2026

Attempt every question from this paper in a timed mock, then review the full solution for each one.

More Sensorineural Function Questions

More INI-CET EXAM -2026 Questions